Latest Safety News

Vertex Minerals has commenced commissioning at its Reward Gold Mine, processing the first ore through a newly installed gravity gold plant. The company anticipates first commercial gold sales by February, marking a significant milestone in its high-tech, environmentally conscious mining strategy.

Korvest Ltd’s first half of FY25 saw profitability pressures from operational setbacks and inflation, but a record order book and new major projects set the stage for a promising second half.

Recce Pharmaceuticals has successfully dosed all patients in its Phase II trial of RECCE® 327 topical gel for acute bacterial skin infections, showing encouraging preliminary efficacy and safety data. The company is preparing for pivotal Phase III trials in Australia and Indonesia, targeting a significant global market opportunity.

Centuria Funds Management Limited reports a stable quarter for its Centuria Capital No. 2 Fund (C2F), with no compliance breaches or adverse financial events in Q2 FY25. The fund’s secured notes remain fully supported by first-ranking security interests, underscoring operational resilience.

Liontown Resources has delivered a robust December quarter, achieving positive net cash flow and record production at its Kathleen Valley lithium project, reinforcing its path to becoming a major sustainable spodumene supplier.

Qoria Limited reports robust December quarter results for FY2025, driven by strong ARR growth, expanding global reach, and strategic AI innovations that promise to accelerate future growth.

Liontown Resources has reported a robust December 2024 quarter at its Kathleen Valley Lithium Operation, delivering strong production and financial results that underscore its trajectory towards becoming a world-class lithium producer.

Hillgrove Resources delivered a robust December quarter with record development and copper production, underpinned by exceptional drilling results at Nugent. The company projects increased output and improved cost efficiency for 2025.

PolyNovo Limited reports a robust 22.8% revenue increase in 1H FY25, driven by strong U.S. and international sales growth and progressing FDA approval efforts for its NovoSorb platform.

Visioneering Technologies reports promising interim results from its PROTECT trial, showing significant control of myopia progression in children using NaturalVue® Multifocal lenses.

Spacetalk Limited reports a robust 12% increase in Annual Recurring Revenue to $11 million, driven by a 21% jump in paid mobile subscribers, signaling strong momentum and international ambitions.

Dimerix has reached a key milestone by enrolling the first paediatric patient aged 12-17 in its ACTION3 Phase 3 trial for DMX-200, advancing its potential treatment for childhood FSGS kidney disease.